FDA issues stronger warning of Topamax birth defect risk
New data has prompted the Food and Drug Administration to warn of an increased risk of cleft palette or cleft lip in infants born to mothers who are taking Topamax during the first trimester of pregnancy. Infants exposed to the drug during the first trimester are several times more likely to develop an oral cleft birth defect.
Topamax is the Johnson & Johnson brand name for topiramate, a pharmaceutical also manufactured under generic labels by several other companies. The medication is approved for the treatment of seizures resulting from epilepsy and is also used in order to prevent migraines.
Based on reviews of data from both the U.K. and North America, the FDA has warned that the risk of oral clefts is increased up to 16 times for mothers taking the medication. Cleft lip or cleft palate occurs when the two sides do not fuse together properly early in a pregnancy. That the potentially harmful effects of Topamax occur so early in the pregnancy is of particular concerns because many women may not even realize that they are pregnant at this early stage.
The drug will now be identified as a Category D drug, meaning that there is evidence in human patients that it poses a fetal risk. It had previously been in Category C because a risk was suspected based only on animal tests. The FDA will also require a more stringent label warning for the drug.
The FDA urges women taking Topamax or generic topiramate to contact their doctor immediately if they become pregnant or are considering pregnancy. Women of childbearing potential are advised to consider alternative medications.
Source: U.S. Food and Drug Administration "FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate)" March 4, 2011
Watch A Quick Video:
*AV®, AV Preeminent®, Martindale-Hubbell Distinguished and Martindale-Hubbell Notable are certification marks used under license in accordance with the Martindale-Hubbell certification procedures, standards and policies. Martindale-Hubbell® is the facilitator of a peer review rating process. Ratings reflect the anonymous opinions of members of the bar and the judiciary. Martindale-Hubbell® Peer Review Ratings™ fall into two categories — legal ability and general ethical standards.
**Board certification is not required to practice law in Illinois, and the Illinois Supreme Court does not recognize specialties in the practice of law.
What Our Clients Say
- Just wanted to take a moment to say thank you. I know a lot of hard work, by all of you, went into the preparation of this case and we wanted you to know that it is greatly appreciated. We worried about many things during that period, but one thing we didn't worry about was our attorneys. What a fine team you make! You guys are great! Read More
- I wanted to touch base with everyone again to express my thanks to everyone involved in the USAir 1016 case for the way the case was handled and the way you treated myself and my family. While I realize that there are other law firms that could have tried the case, I don't believe they could have matched the caring you showed us... Read More
- How do we thank you for doing such a tremendous job with the lawsuit against Freeport Memorial Hospital?...The day that check arrived I was so nervous, in fact I was a wreck until we had it safely invested. I am not thanking you just as our attorney, but as a very good friend...Read More
- We would like to take this opportunity to express our heartfelt thanks for the supportive service that you have given our family during the past three years. While we wish that we would not have found ourselves in a situation requiring your services, we are grateful for the sensitive way...Read More
Email Us For a Response
Have Questions? We Have Answers.
Tell us about your case and we’ll get back to you with a FREE case evaluation.
Bold labels are required.
Premier Personal Injury & Wrongful Death Attorneys
Call 877-216-4213 or Email Us For A Free Initial Consultation